3M CO Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 379.00K shares, a 33.92% increase year-over-year.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 425.00K shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 186.00K shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 1.11M shares.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 10.87M shares, a 4886.70% increase from fiscal 2024.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 218.00K shares, a 85.37% decline from fiscal 2023.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 1.49M shares, a 29.08% decline from fiscal 2022.
- 3M CO share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.10M shares, a 49.53% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 10.87M shares 10-K · filed 2026-02-03 | |
| 2024-12-31 | 218.00K shares 10-K · filed 2025-02-05 | |
| 2023-12-31 | 1.49M shares 10-K · filed 2024-02-07 | |
| 2022-12-31 | 379.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | 2.10M shares 10-K · filed 2023-02-08 |
| 2022-09-30 | 425.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | 2.00M shares derived: sum of 4 quarters · filed 2023-02-08 |
| 2022-06-30 | 186.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | |
| 2022-03-31 | 1.11M shares 10-Q · filed 2022-04-26 | |
| 2021-12-31 | 283.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | 4.16M shares 10-K · filed 2023-02-08 |
| 2020-12-31 | 2.76M shares 10-K · filed 2023-02-08 | |
| 2019-12-31 | 4.19M shares 8-K · filed 2022-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |